* Tectonic Therapeutic Inc TECX.OQ reported a quarterly
adjusted
loss of $1.20 per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of $-5.28. The mean expectation of three analysts
for the quarter was for a loss of 82 cents per share. Wall
Street expected results to range from -95 cents to -70 cents per
share.
* Reported revenue was zero; analysts expected zero.
* Tectonic Therapeutic Inc's reported EPS for the quarter
was a
loss of $1.20.
* The company reported a quarterly loss of $17.72 million.
* Tectonic Therapeutic Inc shares had risen by 48.0% this
quarter and gained 174.8% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 6.5%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"
Wall Street's median 12-month price target for Tectonic
Therapeutic Inc is 55.00
This summary was machine generated from LSEG data November 8 at
05:15 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.82 -1.20 Missed
Jun. 30 2024 -1.50 -4.34 Missed
Mar. 31 2024 -4.32 -1.80 Beat
Dec. 31 2023 -4.04 -2.40 Beat